aTyr Pharma to Participate in Upcoming Investor Conferences
aTyr Pharma, Inc. (NASDAQ: ATYR), a clinical-stage biotechnology company dedicated to discovering and developing groundbreaking medicines through its proprietary tRNA synthetase platform, has announced its participation in several investor conferences taking place in September 2024.
Upcoming Conference Details
The company will be involved in the following conferences:
Wells Fargo Healthcare Conference
Date: Thursday, September 5, 2024
Format: One-on-One Investor Meetings
H.C. Wainwright 26th Annual Global Investment Conference
Date: Wednesday, September 11, 2024
Time: 10:30 AM EDT
Format: Corporate Presentation
Cantor Fitzgerald Global Healthcare Conference
Date: Wednesday, September 18, 2024
Time: 1:55 PM EDT
Format: Corporate Presentation
One-on-One Meetings with Investors
Alongside the presentations, company management will be available for one-on-one meetings with registered investors during the conferences. A webcast of the presentations will be accessible in the Investor section of the company’s website, and a replay will be available for at least 90 days afterward.
About aTyr Pharma
aTyr is a clinical-stage biotechnology company that utilizes evolutionary intelligence to transform tRNA synthetase biology into innovative therapies targeting fibrosis and inflammation. The company’s lead therapeutic candidate, efzofitimod, is a first-in-class biologic immunomodulator currently under development for interstitial lung disease, a condition that can cause inflammation and progressive lung scarring.
Contact Information
For additional inquiries, please reach out to: Ashlee Dunston
Director, Investor Relations and Public Affairs
Email: adunston@atyrpharma.com
Frequently Asked Questions
What is aTyr Pharma known for?
aTyr Pharma is recognized as a biotechnology company that focuses on developing innovative therapies derived from its proprietary tRNA synthetase platform.
What are the dates of the upcoming investor conferences?
The investor conferences are scheduled for September 5, 11, and 18, 2024.
Will aTyr Pharma have one-on-one meetings with investors?
Yes, the management team will be available for one-on-one meetings with registered investors at the conferences.
Where can I access the presentation webcasts?
The webcasts will be available on the Investor section of aTyr Pharma’s website.
Who can I contact for more information?
You can reach out to Ashlee Dunston, the Director of Investor Relations and Public Affairs at aTyr Pharma, for more information.